Longboard Pharmaceuticals, Inc. Total Assets
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
| Total Assets | $56.2M | $109.0M | $70.6M | $50.7M |
Longboard Pharmaceuticals, Inc. (LBPH) Total Assets comparison analysis
General
LTM Total Assets
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
LBPH key stats
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 0.0 0.0% | (0.0) 0.0% | (0.0) 0.0% | (0.0) 0.0% |
| Operating Expenses | 14.4 | 27.8 | 44.8 | 56.8 |
| Research & Development Expenses (R&D) | 4.6 | 19.8 | 34.6 | 43.8 |
| Selling, General & Administrative Expenses (SG&A) | 9.8 | 8.1 | 10.2 | 13.0 |
% margin | (14.4) 0.0% | (27.8) 0.0% | (44.8) 0.0% | (56.8) 0.0% |
| Interest Income | 0.0 | 0.1 | 0.8 | 2.4 |
| Interest Expense | 0.0 | 0.0 | 0.8 | 0.0 |
| Pre-tax Income | (14.4) | (27.8) | (43.9) | (54.4) |
% effective tax rate | (0.0) 0.1% | (0.1) 0.2% | (0.9) 1.9% | 0.0 0.0% |
% margin | (14.4) 0.0% | (27.7) 0.0% | (43.1) 0.0% | (54.4) 0.0% |
| EPS | (0.82) | (1.62) | (2.51) | (2.39) |
| Diluted EPS | (0.82) | (1.62) | (2.51) | (2.39) |
% margin | (14.4) 0.0% | (27.8) 0.0% | (44.8) 0.0% | (56.8) 0.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Longboard Pharmaceuticals, Inc.'s Total Assets?
As of today, Longboard Pharmaceuticals, Inc.'s last 12-month Total Assets is $297.0M, based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Longboard Pharmaceuticals, Inc.'s Total Assets growth rate?
Over the last year, Longboard Pharmaceuticals, Inc.'s Total Assets growth was 404.6%. The average annual Total Assets growth rates for Longboard Pharmaceuticals, Inc. have been 33.9% over the past three years, N/A over the past five years.
3) Is Longboard Pharmaceuticals, Inc.'s Total Assets growth rate Good?
Over the last year, Longboard Pharmaceuticals, Inc.'s Total Assets growth was 404.6%, which is higher than industry growth of (0.1%). It indicates that Longboard Pharmaceuticals, Inc.'s Total Assets growth is Good.